CIK 0001707502
- Non-accelerated filer
- Smaller reporting company
Solid Biosciences Inc.
Sign in to watch- Ticker
- SLDB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 900943402
- Phone
- +1 617-337-4680
- Business address
- 500 RUTHERFORD AVENUE, 3RD FLOOR, CHARLESTOWN, MA, 02129
- Former names
- Solid Biosciences, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $24,582
- in 1 filing, $25K under 10b5-1 plans
Net −$24,582. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-07-28 | Schneider Joel Solomon Zev Chief Technology Officer | Sale | −4,041 | $2.42 | $10K | 284,115 |
| 2020-07-28 | Morris Carl Ashley Chief Scientific Officer | Sale | −3,591 | $2.42 | $9K | 290,959 |
| 2020-07-28 | Ziolkowski Jennifer Lynn CFO, Treasurer & Asst. Secy | Sale | −3,591 | $2.42 | $9K | 327,609 |
| 2020-07-28 | HERSCHA LYNETTE Chief Legal Officer | Sale | −5,141 | $2.42 | $12K | 160,859 |
| 2020-07-28 | Ganot Ilan CEO & President | Sale | −11,124 | $2.42 | $27K | 1,148,007 |
| 2020-07-27 | Ganot Ilan CEO & President | Grant or award · Employee Stock Option (Right to Buy) | +1,350 | 1,350 | ||
| 2020-07-27 | Schneider Joel Solomon Zev Chief Technology Officer | Exercise or conversion | +11,500 | 288,156 | ||
| 2020-07-27 | Schneider Joel Solomon Zev Chief Technology Officer | Exercise or conversion · Restricted Stock Units | −11,500 | 11,500 | ||
| 2020-07-27 | Morris Carl Ashley Chief Scientific Officer | Exercise or conversion | +11,500 | 294,550 | ||
| 2020-07-27 | Morris Carl Ashley Chief Scientific Officer | Exercise or conversion · Restricted Stock Units | −11,500 | 11,500 | ||
| 2020-07-27 | Ziolkowski Jennifer Lynn CFO, Treasurer & Asst. Secy | Exercise or conversion | +11,500 | 331,200 | ||
| 2020-07-27 | Ziolkowski Jennifer Lynn CFO, Treasurer & Asst. Secy | Exercise or conversion · Restricted Stock UNits | −11,500 | 11,500 | ||
| 2020-07-27 | HERSCHA LYNETTE Chief Legal Officer | Exercise or conversion | +16,000 | 166,000 | ||
| 2020-07-27 | HERSCHA LYNETTE Chief Legal Officer | Exercise or conversion · Restricted Stock Units | −16,000 | 16,000 | ||
| 2020-07-27 | Ganot Ilan CEO & President | Exercise or conversion | +35,500 | 1,159,131 | ||
| 2020-07-27 | Ganot Ilan CEO & President | Exercise or conversion · Restricted Stock Units | −35,500 | 35,500 | ||
| 2020-06-16 | Ziolkowski Jennifer Lynn CFO, Treasurer & Asst. Secy | Grant or award | +75,000 | 319,700 | ||
| 2020-06-16 | Schneider Joel Solomon Zev Chief Technology Officer | Grant or award | +75,000 | 276,656 | ||
| 2020-06-16 | Morris Carl Ashley Chief Scientific Officer | Grant or award | +75,000 | 283,050 | ||
| 2020-06-16 | HERSCHA LYNETTE Chief Legal Officer | Grant or award | +75,000 | 150,000 |
Page 24 of 31 · 604 trades